Genetics of antidepressant response and treatment-resistant depression

AN Chung, TT Chen, YF Lin - Progress in Brain Research, 2023 - Elsevier
Antidepressant response, the effectiveness of antidepressants in relieving symptoms of
depression, is a complex trait influenced by both genetic and environmental factors …

Involvement of inflammatory responses in the brain to the onset of major depressive disorder due to stress exposure

S Miyata, Y Ishino, S Shimizu… - Frontiers in Aging …, 2022 - frontiersin.org
Major depressive disorder (MDD) is a multifactorial disease affected by several
environmental factors. Although several potential onset hypotheses have been identified …

Metformin attenuates symptoms of osteoarthritis: role of genetic diversity of Bcl2 and CXCL16 in OA

N Alimoradi, M Tahami, N Firouzabadi, E Haem… - Arthritis Research & …, 2023 - Springer
Objective This study aimed to evaluate the effectiveness of metformin versus placebo in
overweight patients with knee osteoarthritis (OA). In addition, to assess the effects of …

Systems approach to identify common genes and pathways associated with response to selective serotonin reuptake inhibitors and major depression risk

A Srivastava, P Singh, H Gupta, H Kaur… - International journal of …, 2019 - mdpi.com
Despite numerous studies on major depressive disorder (MDD) susceptibility, the precise
underlying molecular mechanism has not been elucidated which restricts the development …

Corticosterone-induced hippocampal 5-HT responses were muted in depressive-like state

X Sun, Y Zu, X Li, S Zhao, X Sun, L Li… - ACS Chemical …, 2021 - ACS Publications
Interactions between the hypothalamic–pituitary–adrenal axis and the central 5-HT system
in the depressive state remain largely unknown. The present study investigated …

[HTML][HTML] Lost in translation. The quest for definitions of treatment-resistant depression with a focus on inflammation-related gene expression

L Sforzini - Brain, behavior, & immunity-health, 2021 - Elsevier
Approximately one third of individuals with major depressive disorder (MDD) do not respond
to antidepressant treatments; but what does treatment-resistant depression (TRD) mean …

Genetic Landscape of Major Depressive Disorder: Assessment of Potential Diagnostic and Antidepressant Response Markers

P Singh, A Srivastava, D Guin, S Thakran… - International Journal …, 2023 - academic.oup.com
Background The clinical heterogeneity in major depressive disorder (MDD), variable
treatment response, and conflicting findings limit the ability of genomics toward the discovery …

Pharmacogenetics and therapeutic drug monitoring of fluoxetine in a real-world setting: A PK/PD analysis of the influence of (non-) genetic factors.

P Magalhães, G Alves, A Fortuna… - Experimental and …, 2020 - psycnet.apa.org
This work presents the GnG-PK/PD-AD study—a pharmacokinetics/pharmacodynamics
(PK/PD) analysis of the impact of genetic and nongenetic factors on the treatment with the …

Analysis of the deleterious single-nucleotide polymorphisms associated with antidepressant efficacy in major depressive disorder

J Xin, M Yuan, Y Peng, J Wang - Frontiers in Psychiatry, 2020 - frontiersin.org
Major depressive disorder (MDD) is a serious mental disease with negative effects on both
mental and physical health of the patient. Currently, antidepressants are among the major …

[HTML][HTML] Association between the Three Polymorphisms of the Glucocorticoid Receptor Gene and the Early Clinical Outcome in Kidney Transplantation Patients

S Mottaghi, MM Sagheb, N Azarpira… - Iranian Journal of …, 2021 - ncbi.nlm.nih.gov
Background: Glucocorticoids are pivotal components of immunosuppressive regimens in
solid organ transplantations. This study aimed to assess the possible association between …